Rashid Ahmed Awan

Rashid Awan practices at Chan Soon-Shiong Medical Center at Windber in Windber, Pennsylvania, part of Chan Soon-Shiong Medical Center at Windber.

Rashid Awan's NPI, 1891765251, was assigned on January 26, 2006. Rashid Awan holds Pennsylvania license MD039622L.

Rashid Awan's primary practice is Chan Soon-Shiong Medical Center at Windber, at 600 Somerset Avenue, Windber, PA 15963 in Somerset County. The practice phone is (814) 467-3000.

Rashid Awan's primary practice is Chan Soon-Shiong Medical Center at Windber in Windber, Pennsylvania, part of Chan Soon-Shiong Medical Center at Windber. Rashid Awan is also affiliated with Conemaugh Memorial Medical Center. The medical group on file is Conemaugh Physicians Group. Dmand AI also links Rashid Awan to 2 more group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Rashid Awan practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Rashid Awan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Rashid Awan is licensed in Pennsylvania.

CMS data shows 189 Medicare services from Rashid Awan across 3 procedure codes in 2024, all of them office visits, for 115 Medicare patients. Medicare paid $12,124 for them. Every service was in an office.

CMS counts 115 Medicare patients who saw Rashid Awan in 2024. The largest group is 75 to 84, with 49 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Rashid Awan's median patient age at 69, with 78% women.

In 2024, Rashid Awan wrote 885 Medicare Part D claims for 237 patients. 81% of them were for generic drugs. CMS names the drug for 691 of them, across 16 drugs with 11 or more claims each, at $1,070,409 in total drug cost. In 2023, CMS named 1,153 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 65 out of 100 for Rashid Awan for performance year 2024, reported as part of a group. Rashid Awan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 7 general payments to Rashid Awan from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 91% of the total. Celgene Corporation paid the most, $90.